Commentary
Tumor Necrosis Factor Inhibitors, Antinuclear Antibodies, and Autoimmunity in Patients With Psoriasis
Fármacos anti-TNF, anticuerpos antinucleares y autoinmunidad en pacientes con psoriasis
P. de la Cueva Dobao
Corresponding author
Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain
Read
5824
Timeswas read the article
2022
Total PDF
3802
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 161 | 13 | 174 |
| 2025 5 | 151 | 31 | 182 |
| 2025 4 | 113 | 18 | 131 |
| 2025 3 | 138 | 18 | 156 |
| 2025 2 | 123 | 31 | 154 |
| 2025 1 | 72 | 28 | 100 |
| 2024 12 | 65 | 21 | 86 |
| 2024 11 | 91 | 47 | 138 |
| 2024 10 | 70 | 27 | 97 |
| 2024 9 | 89 | 23 | 112 |
| 2024 8 | 108 | 64 | 172 |
| 2024 7 | 74 | 27 | 101 |
| 2024 6 | 91 | 28 | 119 |
| 2024 5 | 73 | 41 | 114 |
| 2024 4 | 85 | 21 | 106 |
| 2024 3 | 74 | 31 | 105 |
| 2024 2 | 56 | 36 | 92 |
| 2024 1 | 51 | 31 | 82 |
| 2023 12 | 37 | 16 | 53 |
| 2023 11 | 64 | 26 | 90 |
| 2023 10 | 49 | 24 | 73 |
| 2023 9 | 55 | 32 | 87 |
| 2023 8 | 31 | 10 | 41 |
| 2023 7 | 47 | 29 | 76 |
| 2023 6 | 40 | 22 | 62 |
| 2023 5 | 38 | 30 | 68 |
| 2023 4 | 31 | 16 | 47 |
| 2023 3 | 31 | 22 | 53 |
| 2023 2 | 40 | 25 | 65 |
| 2023 1 | 36 | 33 | 69 |
| 2022 12 | 46 | 50 | 96 |
| 2022 11 | 23 | 35 | 58 |
| 2022 10 | 29 | 14 | 43 |
| 2022 9 | 21 | 35 | 56 |
| 2022 8 | 26 | 37 | 63 |
| 2022 7 | 27 | 27 | 54 |
| 2022 6 | 22 | 25 | 47 |
| 2022 5 | 54 | 37 | 91 |
| 2022 4 | 39 | 31 | 70 |
| 2022 3 | 52 | 43 | 95 |
| 2022 2 | 35 | 20 | 55 |
| 2022 1 | 54 | 39 | 93 |
| 2021 12 | 35 | 31 | 66 |
| 2021 11 | 36 | 47 | 83 |
| 2021 10 | 36 | 58 | 94 |
| 2021 9 | 28 | 41 | 69 |
| 2021 8 | 24 | 35 | 59 |
| 2021 7 | 35 | 23 | 58 |
| 2021 6 | 21 | 36 | 57 |
| 2021 5 | 33 | 44 | 77 |
| 2021 4 | 47 | 68 | 115 |
| 2021 3 | 63 | 31 | 94 |
| 2021 2 | 56 | 36 | 92 |
| 2021 1 | 31 | 20 | 51 |
| 2020 12 | 32 | 23 | 55 |
| 2020 11 | 17 | 22 | 39 |
| 2020 10 | 33 | 9 | 42 |
| 2020 9 | 49 | 25 | 74 |
| 2020 8 | 36 | 25 | 61 |
| 2020 7 | 26 | 20 | 46 |
| 2020 6 | 34 | 34 | 68 |
| 2020 5 | 16 | 13 | 29 |
| 2020 4 | 26 | 17 | 43 |
| 2020 3 | 23 | 12 | 35 |
| 2020 2 | 3 | 0 | 3 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 9 | 0 | 9 |
| 2019 11 | 4 | 0 | 4 |
| 2019 9 | 5 | 0 | 5 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 8 | 0 | 8 |
| 2019 6 | 2 | 0 | 2 |
| 2019 5 | 7 | 0 | 7 |
| 2019 4 | 4 | 0 | 4 |
| 2019 3 | 2 | 0 | 2 |
| 2019 2 | 2 | 0 | 2 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 8 | 0 | 8 |
| 2018 10 | 11 | 0 | 11 |
| 2018 2 | 37 | 8 | 45 |
| 2018 1 | 42 | 12 | 54 |
| 2017 12 | 48 | 10 | 58 |
| 2017 11 | 32 | 9 | 41 |
| 2017 10 | 30 | 16 | 46 |
| 2017 9 | 30 | 11 | 41 |
| 2017 8 | 31 | 10 | 41 |
| 2017 7 | 31 | 14 | 45 |
| 2017 6 | 92 | 38 | 130 |
| 2017 5 | 3 | 10 | 13 |
Show all
